virology
422 projects
FP6Reintegration grant2005–2006Greece
HIV-1 PHYLOGENY · Assessment of the accuracy of different phylogenetic methods for HIV-1 contact tracing and HIV-1 molecular epidemiology in Greece
FP6Reintegration grant2005–2006Poland
MOLECULARCLOCK TOOLS · Development of tools for the analysis of molecular clock and their application for a case of Hepatitis C Virus epidemics with known infection history
FP6Individual fellowship2005–2007United Kingdom
I.S.Q.C. · Improving seed quality in cereals by manipulating gene expression and partitioning
FP6Individual fellowship2005–2007France
CROSS PRESENTATION · Antigen presentation and T cell-mediated immunity: membrane trafficking in cross-presentation
FP6Individual fellowship2005–2007France
RNA CUREPPR · RNA interference as a potential control of peste des petits ruminants
FP6Other2005–2007Ireland
VIRAL IMMUNE EVASION · Using viral inhibitors to characterise signalling pathways involved in interferon induction
FP6Individual fellowship2005–2006United Kingdom
PLANTIRABIES · GENERATION OF NEW ANTI-RABIES ANTIBODIES FOR POST EXPOSURE PROPHYLAXIS AND PRODUCTION IN PLANTS.
FP6Reintegration grant2005–2005Poland
MBLUKP · Clinical consequences of mannose binding lectin dysfunction.
FP6Individual fellowship2004–2006Norway
CLM RECEPTOR FAMILY · CMRF35-like molecules: a novel receptor family involved in the control of myeloid cell function
FP6Reintegration grant2004–2005Germany
PML NUCLEAR BODIES · Function and regulation of promyelocytic leukemia (PML) nuclear bodies (NB) and their role in innate immunity and antiviral resistance
FP6Individual fellowship2004–2007Netherlands
PKCEPSILON AND ALCOHOL · Amygdala CRF in reduced anxiety and alcohol consumption in PKCepsilon null mice
FP6Individual fellowship2004–2005United Kingdom
MEASURE RISK! · The Validity of Different Survey Methods to Measure Risk Behaviour for Hiv the Sti - Comparison of Self-Reports the Biomedical Data
FP6Individual fellowship2004–2006Italy
ELEUTHESYNTHESIS · Synthesis of Eleutheside Analogues : Potential Microtubule-Stabilizing Anticancer Drugs
FP6Individual fellowship2004–2005Netherlands
J.A. RODRIGUEZ-FEO · Role of caveosome-medicated endocytosis during MMP-2 activation
FP6Individual fellowship2004–2006Germany
HBVENTRYVISUALISED · Visualisation of the early steps of human hepatitis B virus infection: a colourful approach
FP5Individual fellowship2003–2004Germany
XANDER DE HAAN · The use of vaccinia virus infection as a model system to study interactions between the endoplasmic reticulum and microtubules
FP5Doctoral network2002–2006France
SDO · Silencing in different organisms
6 partners · 5 countries
FP5Training site2002–2006Netherlands
DC-TARGETING · Developing tumor vaccines, that utilise bodies own immune system, through dc targeting.
FP5Training site2002–2006Belgium
Theoretical research on charge correlation in low dimensional systems
FP5Training site2002–2006Slovenia
Pt (ii) and pd (ii) complexes with oligonucleotides and dna constituents as virus inhibitors
FP5Individual fellowship2001–2003United Kingdom
Localisation, dynamics and regulation of herpes simplex virus type 1 genomes in lytic and quiescent infection
FP5Individual fellowship2000–2001Italy
TSWV · Immunotherapy for plant protection against tomato spotted wilt virus (TSWV)
FP5Individual fellowship2000–2002Germany
Vaccinia virus, a model system to study microtubule motors and centrosome fuction.
FP4Individual fellowship1998–2001Netherlands
